Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Azd8965 low dose's trials
ARGiNAUT
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
AZD8965 low dose
Ongoing
Recruiting
Phase 2
Open NCT07652658 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
ARGiNAUT · Trial Tracker · ComplyRx
